Global Cyclodextrins Market – Industry Trends and Forecast to 2031

Cyclodextrins Market Analysis and Size

In the pharmaceutical industry, cyclodextrins play a crucial role as excipients and drug delivery agents. They are used primarily to improve the solubility, stability, and bioavailability of poorly soluble drugs by forming inclusion complexes. This enhancement allows for easier formulation of medicines that would otherwise exhibit low solubility in water or other common solvents. Cyclodextrins also help in masking unpleasant tastes or odors of certain drugs, thereby improving patient compliance. They enable controlled release of drugs, enhancing their therapeutic efficacy and safety profiles.

The global cyclodextrins market size was valued at USD 344.35 million in 2023 and is projected to reach USD 439.62 million by 2031, with a CAGR of 3.10% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Report Scope and Market Segmentation       

Market Definition

Cyclodextrins are cyclic oligosaccharides composed of glucose units arranged in a ring-such as structure. They are typically produced from starch by enzymatic conversion and are known for their ability to form inclusion complexes with guest molecules. This unique property allows cyclodextrins to enhance the stability, solubility, and bioavailability of various compounds in industries such as pharmaceuticals, food, cosmetics, and agriculture. Cyclodextrins are widely used in drug delivery systems, flavor encapsulation, and as complexing agents in various applications.

Cyclodextrins Market Dynamics

Drivers

• Growing Demand for Enhanced Stability

Cyclodextrins are valued for their ability to improve the stability of active pharmaceutical ingredients (APIs) by forming inclusion complexes that protect them from degradation and enhance their solubility. This stability is crucial for maintaining the efficacy and shelf-life of pharmaceutical formulations, ensuring consistent therapeutic outcomes for patients. Similarly, in industries such as cosmetics and food, cyclodextrins are utilized to stabilize sensitive ingredients, preserve their potency, and extend product shelf-life. This capability addresses consumer preferences for products that offer reliable performance and quality over time, driving manufacturers to integrate cyclodextrins into their formulations for enhanced stability and improved market competitiveness.

• Growing Food and Beverage Sector

Cyclodextrins are utilized extensively in this industry for encapsulating flavors and fragrances, which enhances their stability and prolongs their shelf life. Additionally, cyclodextrins are employed to mask undesirable tastes or odors in food products, improving overall consumer acceptance. They also aid in stabilizing sensitive ingredients, such as vitamins and antioxidants, thereby maintaining their efficacy throughout food processing and storage. As consumer demand grows for natural and clean-label products, cyclodextrins offer a versatile solution to meet these requirements while supporting innovation in food formulation and product development.

Opportunities

• Growing Technological Advancements

Technological advancements include improvements in manufacturing processes, such as enzymatic modification and green chemistry approaches, which enhance the efficiency and sustainability of cyclodextrin production. Moreover, advancements in analytical techniques allow for better characterization and application of cyclodextrins in various industries. In pharmaceuticals, for instance, innovative drug delivery systems and formulations benefit from novel cyclodextrin complexes that improve drug solubility and bioavailability. Advancements in nanotechnology and materials science contribute to new applications of cyclodextrins in targeted drug delivery and biomedical fields, expanding their market potential.

• Increasing Regulatory Requirements

Regulatory bodies worldwide impose stringent guidelines on pharmaceuticals, cosmetics, food additives, and agrochemicals to ensure product safety, efficacy, and environmental sustainability. Cyclodextrins, with their ability to encapsulate and control the release of active ingredients, help companies meet these regulatory standards by enhancing the stability, bioavailability, and safety profiles of products. As regulations evolve to address environmental concerns and consumer health, the demand for cyclodextrins rises, as they offer solutions for reducing environmental impact, improving product efficacy, and complying with stringent regulatory frameworks.

Restraints/Challenges

• Limited Awareness

Despite their versatile applications and benefits in industries such as pharmaceuticals, food, cosmetics, and agriculture, many potential users, including formulators and consumers, may not fully understand the advantages or potential uses of cyclodextrins. This lack of awareness can result in hesitancy or reluctance to adopt cyclodextrins in product formulations or processes, thereby limiting market penetration and growth.

• Competitive Alternatives

Other excipients and encapsulation technologies, such as liposomes, microspheres, and solid lipid nanoparticles, offer similar functionalities such as improved solubility, stability, and controlled release of active ingredients at potentially lower costs. These alternatives may appeal to manufacturers looking to reduce production expenses or explore different formulation strategies. Additionally, advancements in polymer-based excipients and nanotechnology further intensify competition by offering enhanced delivery efficiencies and novel functionalities.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Cyclodextrins Market Scope

The market is segmented on the basis of product type and application. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product Type

• Alpha- Cyclodextrin
• Beta- Cyclodextrin and Gamma-Cyclodextrin
• Cyclodextrin Derivatives

Application

• Food and Beverages
  • Bakeries
  • Confectionaries
  • Others
    • Mayonnaise
    • Whip Cream
• Pharmaceuticals
• Cosmetics
• Chemicals
• Others
  • Agricultural Engineering
  • Environmental Engineering

Cyclodextrins Market Regional Analysis/Insights

The market is analyses and market size, volume information is provided by country, product type and application as referenced above.

The countries covered in market  are U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Brazil, Argentina, Rest of South America, U.A.E., Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa(MEA).

North America dominates the market due to widespread utilization across diverse industries such as pharmaceuticals, food and beverage, and cosmetics. The region benefits from advanced research and development capabilities, robust manufacturing infrastructure, and strong regulatory frameworks supporting cyclodextrin applications. As these industries increasingly seek innovative solutions for drug delivery, flavor encapsulation, and stabilization of active ingredients, the demand for cyclodextrins in North America is expected to grow steadily, reinforcing its position as a key market leader in the forecast period.

Asia-Pacific is expected to grow during the forecast period due to several key factors. Urbanization and westernization trends are driving changes in consumer preferences and lifestyles, particularly towards increased consumption of beverages. The expanding beverages industry in the region is capitalizing on these trends, supported by rising personal disposable incomes. These factors collectively contribute to a favorable environment for robust growth in the Asia-Pacific market over the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Cyclodextrins Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• CTD Holdings, Inc. (U.S.)
• Wacker Chemie AG (Germany)
• Cyclolab (Hungary)
• Merck KGaA (Germany)
• NIHON SHOKUHIN KAKO CO., LTD. (Japan)
• Roquette Frères (France)
• Ashland (U.S.)
• Shandong Xinda Biological Technology Co., Ltd. (China)
• Yunan County Yongguang Group (China)
• Mengzhou Hongji Biological Co., Ltd. (China)
• Gangwal Chemicals Pvt. Ltd. (India)
• Geno (Norway)
• Fengchen Group Co., Ltd. (China)
• Cayman Chemical (U.S.)
• Zhonglan Industry Co., Ltd. (China)
• Shandong Binzhou Zhiyuan Biotechnology Co., Ltd. (China)
• Captisol (U.S.)

SKU-46219